New therapies in Crohn disease

Subrata Ghosh

New therapies in Crohn disease

Subrata Ghosh

Imperial College Healthcare NHS Trust

Research output: Contribution to journal › Review article › peer-review

Abstract

Several therapeutic avenues are being explored in search of pharmaceutical agents to reduce inflammatory symptoms in patients with Crohn disease (CD). Initial cost for some agents may be high, but cost-effectiveness studies may show a reduction in the need for hospitalization or surgery in these patients. The search for new, inexpensive agents that effectively manage CD continues.

Original language	English
Pages (from-to)	29-35
Number of pages	7
Journal	Drug Benefit Trends
Volume	15
Issue number	SUPPL. A
Publication status	Published - 1 Apr 2003
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anti-inflammatory agents
Crohn disease
Immunotherapy
Inflammatory bowel disease
Ulcerative colitis

Cite this

@article{7fa5d2b116124b97937b530ac9f703f5,

title = "New therapies in Crohn disease",

abstract = "Several therapeutic avenues are being explored in search of pharmaceutical agents to reduce inflammatory symptoms in patients with Crohn disease (CD). Initial cost for some agents may be high, but cost-effectiveness studies may show a reduction in the need for hospitalization or surgery in these patients. The search for new, inexpensive agents that effectively manage CD continues.",

keywords = "Anti-inflammatory agents, Crohn disease, Immunotherapy, Inflammatory bowel disease, Ulcerative colitis",

author = "Subrata Ghosh",

year = "2003",

month = apr,

day = "1",

language = "English",

volume = "15",

pages = "29--35",

journal = "Drug Benefit Trends",

issn = "1080-5826",

publisher = "Cliggott Publishing Co.",

number = "SUPPL. A",

}

TY - JOUR

T1 - New therapies in Crohn disease

AU - Ghosh, Subrata

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Several therapeutic avenues are being explored in search of pharmaceutical agents to reduce inflammatory symptoms in patients with Crohn disease (CD). Initial cost for some agents may be high, but cost-effectiveness studies may show a reduction in the need for hospitalization or surgery in these patients. The search for new, inexpensive agents that effectively manage CD continues.

AB - Several therapeutic avenues are being explored in search of pharmaceutical agents to reduce inflammatory symptoms in patients with Crohn disease (CD). Initial cost for some agents may be high, but cost-effectiveness studies may show a reduction in the need for hospitalization or surgery in these patients. The search for new, inexpensive agents that effectively manage CD continues.

KW - Anti-inflammatory agents

KW - Crohn disease

KW - Immunotherapy

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - https://www.scopus.com/pages/publications/0037716775

M3 - Review article

AN - SCOPUS:0037716775

SN - 1080-5826

VL - 15

SP - 29

EP - 35

JO - Drug Benefit Trends

JF - Drug Benefit Trends

IS - SUPPL. A

ER -

New therapies in Crohn disease

Abstract

UN SDGs

Keywords

Other files and links

Fingerprint

Cite this